Skip to main content
Observe Medical
AboutProductsBecome a DistributorInvestorsNewsNexusContact
Nexus
Clinical team in a Nordic ICU monitoring a patient with digital equipment

Nordic medtech for critical care

Fighting infection and improving workflows

CAUTI remains one of the most common hospital-acquired infections, despite being largely preventable.
Manually reading and documenting ICU urine output is a time-consuming task that pulls nurses away from patient care.

Read more

Manually reading and documenting ICU urine output is a time-consuming task that pulls nurses away from patient care.

For clinicians· See the evidence→For procurement· Model your savings→For distributors· Partner with us→
46
Countries using the UnoMeter™ family
30
Years as a standard of care in ICU urine measurement
14 days
Of safe use
100%
Barrier against retrograde migration
UnoMeter™ Safeti™ Max · The 14-day system

What a 14-day closed system changes New

UnoMeter™ Safeti™ Max provides a fully documented 100% barrier against retrograde migration over 14 days, preventing bacteria- and biofilm-mediated ascending urinary infections originating from the urine meter.

€80,391
Modelled infection-cost savings
Modelled savings per 1,000 ICU patients. The model assumes reduced intra-luminal contamination, based on the in vitro barrier data.
75 hrs
Nursing time released
Fewer urine meter exchanges can release a modelled 75 nursing hours per 1,000 patients.
24%
Fewer units used
Moving from 7-day to 14-day systems means fewer meters used per patient, and a lower total cost of monitoring.
432,000 kg
Waste avoided
Modelled annual waste reduction at full European conversion to 14-day systems.
All figures are modelled estimates based on published literature and stated assumptions. Actual results vary by institution, patient volume and clinical protocol.
See the detail
24%
Fewer units used
Moving from 7-day to 14-day systems means fewer meters used per patient, and a lower total cost of monitoring.
432,000 kg
Waste avoided
Modelled annual waste reduction at full European conversion to 14-day systems.
All figures are modelled estimates based on published literature and stated assumptions. Actual results vary by institution, patient volume and clinical protocol.

Our ambition

A Nordic medtech platform. Built to carry more than our own products.

Two strategic pillars drive the company.

01
Pillar 01

In-house developed medtech

Bringing innovative in-house developed medtech products to market with superior and well-documented clinical performance, health economics and sustainability by design.

02
Pillar 02

The Nordic ecosystem

Representing the Nordic ecosystem of innovative companies within the medtech world by offering scalable solutions in manufacturing, regulatory, quality and commercialisation.

The clinical challenge

Significant costs and patient implications of choosing the wrong urine meter

The choice of urine meter will have a direct impact on patient outcomes, the health-economic impact, and how much time and effort the nurse has to put into the process of reading and documenting urine output; the right choice will drive reduced costs, fewer nursing hours used, and improved patient outcomes.

>40%
of hospital-acquired infections are catheter-associated and thereby linked directly to the use of a urine meter

Catheter-associated urinary tract infections (CAUTIs) remain among the most common healthcare-associated infections and are considered largely preventable.

Source: Maki og Tambyah, Emerging Infectious Diseases, 2001

Key Impact
  • €80,391modelled savingsper 1,000 patients
  • 1 to 3extra hospital daysper CAUTI patient
37min
Nursing time per shift

ICU nurses spend an average of 37 minutes per shift installing, reading, recording, and documenting urine measurements. Time that could be spent on direct patient care.

Key Impact
  • 75modelled hrsnursing hours released per 1,000 patients by using a 14-day system
  • 6+hoursof nursing time lost per day (10-bed ICU)
432,000
kg of avoidable waste from single-use products

Every time a urine meter is exchanged, this drives waste and time consumption. Longer dwell times mean fewer installations, fewer consumables, and more clinical waste per patient. Moving from 7-day to 14-day systems removes a modelled 432,000 kg across a full European conversion.

Key Impact
  • 24%lessurine meter used with the 14-day system
  • 360lessurine meter exchanges for the nurse to conduct for every 1000 patients treated
Read more about the challenge →
The portfolio

UnoMeters™ are setting the standard today. The successor is in preperation

The UnoMeter™ family has continued to define the market standards of the last 30 years with performance that hospitals and patients rely on. UnoMeter™ SafetiMax™ is now redefining the standards of today, and our digital UnoMeter™ Sippi® will be defining the standards of tomorrow.

Explore our products
Manual closed system · In use today

UnoMeter™

Seven closed-system urine meters are used by clinical teams in 46 countries.

Explore UnoMeter™ →
Digital · Next generation

UnoMeter™ Sippi®

Our next-generation digital urine meter, designed for continuous, automated measurement and direct data integration.

Explore UnoMeter™ Sippi® →

CE marked under EU MDR·ISO 13485 certified·46 countries·30 years in critical care

Find your pathway

What brings you here?

Clinical teams

Evidence, product detail and evaluation support.

Request a clinical evaluation →

Procurement

Tender documentation, health economics and logistics data.

Request a tender pack →

Distributors

Partnership model, market opportunity and how to apply.

Apply for partnership →

Investors

Reports, share information and the financial calendar.

Visit investor relations →

Talk to us about urine output monitoring in your ICU

Clinical questions, product evaluations and distributor enquiries - one contact form, routed to the right team.

Contact salesBecome a distributor
Observe Medical

Nordic medtech company advancing urine output monitoring in critical care - reducing infection risk and freeing clinical time in the ICU.

Follow us on LinkedIn

Products

  • UnoMeter™ Safeti Max
  • UnoMeter™ Safeti Plus
  • UnoMeter™ 500
  • UnoMeter™ Abdo‑Pressure
  • All products
  • Sippi®In development

Company

  • About us
  • Clinical evidence
  • News
  • Careers
  • Distributors
  • Procurement

Investors

  • Share information
  • Reports & presentations
  • Financial calendar
  • Stock exchange notices
  • Subscribe to releases
OBSRVListed on Euronext Expand Oslo

Contact

Headquarters

Observe Medical ASA

Dronning Eufemias gate 16

0191 Oslo, Norway

Sales & distributors

sales@observemedical.com

Orders & logistics

order@observemedical.com
Quality & regulatoryISO 13485 certifiedCE marked under EU MDR 2017/745

© 2026 Observe Medical ASA · All rights reserved.

Sippi®, UnoMeter™, UnoSafeCoat™, Safeti™, Abdo-Pressure™ and KombiKon™ are trademarks of Observe Medical ASA. This website is intended for healthcare professionals, procurement and distribution partners. Product availability and regulatory status vary by country; please contact your local distributor. Sippi® is in development and is not available for sale.

Latest from Observe Medical

Press releases and announcements

View all news →
Non-regulatory9 October 2026

Observe Medical Secures Significant First Order from Portugal that Validates Expanded Product Portfolio Strategy

Oslo, 9 October 2026 - Observe Medical ASA (the "Company" or "Observe Medical") today announces that it has received its first significant order from Portugal for its newly launched UnoMeter™ A4 Closed System bag.

Read full press release: Observe Medical Secures Significant First Order from Portugal that Validates Expanded Product Portfolio Strategy →
Non-regulatory8 October 2026

Observe Medical ASA: Invitation to presentation with trading update 10 November 2026

Oslo, 8 October 2026 – Observe Medical ASA (OSE: OBSRV) ("the Company" or "Observe Medical") is pleased to invite investors, analysts and other stakeholders to a presentation and trading update on Tuesday, 10 November 2026.

Read full press release: Observe Medical ASA: Invitation to presentation with trading update 10 November 2026 →
Non-regulatory30 September 2026

Observe Medical Announces Repeat Order for UnoMeter Safeti MAX Following Successful Customer Evaluation

Oslo, 30 September 2026 - Observe Medical ASA (the "Company" or "Observe Medical") today announces a repeat customer order for UnoMeter Safeti MAX, following a comprehensive customer evaluation and successful testing of the product and its unique, patented technology.

Read full press release: Observe Medical Announces Repeat Order for UnoMeter Safeti MAX Following Successful Customer Evaluation →
Non-regulatory22 September 2026

Observe Medical Launches New Website to Strengthen Dialogue with Healthcare Decision-Makers Around Innovative UnoMeter™ Safeti™ Max

Oslo, 22 September 2026 - Observe Medical ASA (the "Company" or "Observe Medical") today announces the launch of its new website, designed to create a direct, responsive dialogue with healthcare decision-makers about UnoMeter™ Safeti™ Max, an innovative solution with the potential to deliver clear clinical and…

Read full press release: Observe Medical Launches New Website to Strengthen Dialogue with Healthcare Decision-Makers Around Innovative UnoMeter™ Safeti™ Max →
Regulatory16 September 2026

Correction – Responsibility Statement included in the Interim Report H1 2026

Reference is made to Observe Medical ASA's Interim Report H1 2026 published on August 25, 2026. Please find attached the Interim Report H1 2026, now including the Responsibility Statement. No other changes have been made to the report.

Read full press release: Correction – Responsibility Statement included in the Interim Report H1 2026 →
Non-regulatory10 September 2026

Observe Medical announces first order and the establishment of a distributor partnership in the attractive Philippine market

Oslo, 10 September 2026 – Observe Medical ASA (the "Company" or "Observe Medical") is pleased to announce our entry into the Philippine market after having received the first significant order of UnoMeter Safeti Plus and UnoMeter Safeti Max.

Read full press release: Observe Medical announces first order and the establishment of a distributor partnership in the attractive Philippine market →
Edit with